On Friday, BeiGene Ltd ADR (NASDAQ: ONC) opened higher 2.38% from the last session, before settling in for the closing price of $225.49. Price fluctuations for ONC have ranged from $126.97 to $248.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 86.75% annually for the last half of the decade. Company’s average yearly earnings per share was noted 36.11% at the time writing. With a float of $96.42 million, this company’s outstanding shares have now reached $97.25 million.
In an organization with 10000 employees, it is important to assess its efficiency.
BeiGene Ltd ADR (ONC) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of BeiGene Ltd ADR is 1.48%, while institutional ownership is 43.94%. The most recent insider transaction that took place on Feb 04 ’25, was worth 9,424,955. In this transaction Chair, Scientific Advisory Brd of this company sold 41,760 shares at a rate of $225.69, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 07 ’25, when Company’s Chair, Scientific Advisory Brd sold 41,760 for $176.50, making the entire transaction worth $7,370,515. This insider now owns 0 shares in total.
BeiGene Ltd ADR (ONC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 36.11% per share during the next fiscal year.
BeiGene Ltd ADR (NASDAQ: ONC) Trading Performance Indicators
Check out the current performance indicators for BeiGene Ltd ADR (ONC). In the past quarter, the stock posted a quick ratio of 1.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.24, a number that is poised to hit -0.98 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of BeiGene Ltd ADR (ONC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.32 million. That was inferior than the volume of 0.33 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.13%. Additionally, its Average True Range was 7.24.
During the past 100 days, BeiGene Ltd ADR’s (ONC) raw stochastic average was set at 77.58%, which indicates a significant increase from 77.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.08% in the past 14 days, which was lower than the 40.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $201.38, while its 200-day Moving Average is $187.99. However, in the short run, BeiGene Ltd ADR’s stock first resistance to watch stands at $234.61. Second resistance stands at $238.35. The third major resistance level sits at $241.71. If the price goes on to break the first support level at $227.51, it is likely to go to the next support level at $224.15. The third support level lies at $220.41 if the price breaches the second support level.
BeiGene Ltd ADR (NASDAQ: ONC) Key Stats
There are currently 97,817K shares outstanding in the company with a market cap of 22.59 billion. Presently, the company’s annual sales total 2,459 M according to its annual income of -881,710 K. Last quarter, the company’s sales amounted to 1,002 M and its income totaled -121,350 K.
